Previous studies in obese rodents and diet-induced obesity models have shown that GEs primary site of action is central, particularly within hypothalamic regions such as the supramammillary nucleus, lateral hypothalamus, and the nucleus of the solitary tract (Tiano et al., 2015)
"So to me, this weight loss medication is kind of the same old story." It is illegal for companies to advertise prescription-only medication, including weight loss injections, in Australia, according to the Therapeutic Goods Administration
Although the body produces it naturally, factors like stress, poor diet, ageing, pollution and illness can reduce its levels, making supplementation helpful for many individuals
Pt-141 is a Bremelanotide, which is a synthetic peptide primarily used to treat sexual dysfunction in women